Symbol Name ID |
Alk
anaplastic lymphoma kinase MGI:103305 |
Reference
|
J:228124 Cazes A, Lopez-Delisle L, Tsarovina K, Pierre-Eugene C, De Preter K, Peuchmaur M, Nicolas A, Provost C, Louis-Brennetot C, Daveau R, Kumps C, Cascone I, Schleiermacher G, Prignon A, Speleman F, Rohrer H, Delattre O, Janoueix-Lerosey I, Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma. Oncotarget. 2014 May 15;5(9):2688-702 |
Age | E16 | P |
Immunohistochemistry (section) | ||
In situ RNA (section) | ||
Immunohistochemistry (whole mount) | ||
In situ RNA (whole mount) | ||
In situ reporter (knock in) | ||
Northern blot | ||
Western blot | ||
RT-PCR | ![]() |
![]() |
cDNA clones | ||
RNase protection | ||
Nuclease S1 | ||
Primer Extension |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/17/2024 MGI 6.24 |
![]() |
|